Drug Database
Back to search

Italy· 034104012

MEGEXIA

A megestrol product containing megestrolo, registered in Italy by SOPHOS BIOTECH S.R.L., on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC L02AB01

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedMEGEXIAATCL02AB01REGISTER NO.034104012PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about megestroloAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Megestrol is registered in 11 of 19 countries.

Countries holding a registration under ATC L02AB01 (megestrol), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 7 of them publish a price we can compare per daily dose
Search megestrol products by name

Megestrol · ATC L02AB01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of megestrol costs, country by country.

Normalised to the WHO defined daily dose (0.16 g), so markets compare like for like.

  • Italy: $2.30 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Megestrol · price per daily dose (0.16 g)

USD · FX 28 Sept 2026

  • IT Italy$2.30
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AIFA (Italy)
Active substance
Megestrolo
Manufacturer
SOPHOS BIOTECH S.R.L.
Country
Italy (IT)
ATC code
L02AB01
ATC class
Megestrol
Defined daily dose
0.16 g, O
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    034104012
    "160 MG COMPRESSE" 30 COMPRESSE
    EUR 60.69

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

152 interactions on record for megestrol.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check megestrol against other medicinesHow interaction checks work

Megestrol · interactions on record

152 records

  • 2 severe
  • 147 moderate
  • 3 minor

Most severe, free to view

  • DofetilideC01BD04severe
  • ThalidomideL04AX02severe
  • AprepitantA04AD12moderate
  • LiraglutidA08AX02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Megestrol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All megestrol products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Belgium · Megace
  • Cyprus · Megace
  • Czechia · Megace, Megaplex
  • Germany · Megestat
  • Spain · Borea, Maygace Altas Dosis
  • France · Megace
  • United Kingdom (Northern Ireland) · Megace
  • Greece · Megace
  • Croatia · Megace, Megostat
  • Hungary · Cachexi, Megace
  • Ireland · Megace
  • Lithuania · Megace
  • Luxembourg · Megace
  • Netherlands · Megestrolacetaat Focus
  • Norway · Megace
  • Poland · Cachexan, Megace
  • Portugal · Megace, Megestrol Generis
  • Romania · Megesin
  • Sweden · Megace
  • Slovenia · Megace
  • Slovakia · Megesin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/afd21c2d-73fc-41b1-9720-1473b96bd6d3
GET /v1/drugs/afd21c2d-73fc-41b1-9720-1473b96bd6d3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"160 MG COMPRESSE\" 30 COMPRESSE",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Megestrolo",
  "reference_pack": "30 UNITA' 160 MG - USO ORALE",
  "public_price_eur": 60.69,
  "ssn_reference_price_eur": 66.79
}
API referenceMCP serverPlans

See everything about megestrol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console